Davita Claremore Dialysis Center is a medicare approved dialysis facility center in Claremore, Oklahoma and it has 16 dialysis stations. It is located in Rogers county at 202 E Blue Starr Dr, Claremore, OK, 74017. You can reach out to the office of Davita Claremore Dialysis Center at (918) 342-1119. This dialysis clinic is managed and/or owned by Davita. Davita Claremore Dialysis Center has the following ownership type - Profit. It was first certified by medicare in October, 1990. The medicare id for this facility is 372514 and it accepts patients under medicare ESRD program.
| Name | Davita Claremore Dialysis Center |
|---|---|
| Location | 202 E Blue Starr Dr, Claremore, Oklahoma |
| No. of Dialysis Stations | 16 |
| Medicare ID | 372514 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| NPI Number | 1154383487 |
| Match | Possible same name, address or phone number |
| Organization Name | Renal Treatment Centers West Inc |
| Doing Business As | Claremore Dialysis Center |
| Address | 202 E Blue Starr Dr, Claremore, Oklahoma 74017 |
| Phone Number | (918) 342-1119 |
| Dialysis patients with Hemoglobin data | 12 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 8 |
For adult patients on hemodialysis, Kt/V should be at least 1.2 and for peritoneal dialysis at least 1.7; that means they are receiving the right amount of dialysis. For pediatric patients, Kt/V should be at least 1.2 on hemodialysis and 1.8 on peritoneal dialysis.
Higher percentages are better.
| Adult patients getting regular hemodialysis at the center | 36 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 332 |
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita Claremore Dialysis Center with elevated calcium levels.
| Patients in the hypercalcemia summary | 39 |
| Hypercalcemia patient months | 348 |
| Patients in the serum phosphorus summary | 41 |
The arteriovenous (AV) fistula is considered the best long-term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arteriovenous fistula and catheter summaries | 38 |
| Patient months included in arteriovenous fistula and catheter summaries | 350 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistula for their treatment | 68.9 |
| Percentage of patients receiving treatment through a vascular catheter for 90 days or longer | 25 |
The rate of hospitalization shows you whether patients who were being treated regularly at Davita Claremore Dialysis Center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standardized Hospitalization Ratio (SHR) Period | January, 2024 - December, 2024 |
| Patients in facility's Hospitalization Summary | 40 |
| Hospitalization Rate in facility | 79.7 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 177.6 |
| Hospitalization Rate: Lower Confidence Limit | 39.5 |
The rate of readmission shows you whether patients who were being treated regularly at Davita Claremore Dialysis Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standardized Readmission Ratio (SRR) Period | January, 2024 - December, 2024 |
| Readmission Rate in facility | 20.5 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 45.3 |
| Readmission Rate: Lower Confidence Limit | 5.4 |
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Davita Claremore Dialysis Center's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standardized Transfusion Ratio (STrR) Period | January, 2024 - December, 2024 |
| Patients in facility's Transfusion Summary | 18 |
The rate of mortality shows you whether patients who were being treated regularly at Davita Claremore Dialysis Center lived longer than expected (better than expected), did not live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standardized Mortality Ratio (SMR) Period | January, 2021 - December, 2024 |
| Patients in facility's Survival Summary | 158 |
| Mortality Rate in facility | 20.2 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 31.3 |
| Mortality Rate: Lower Confidence Limit | 12.3 |
Fresenius Kidney Care Claremore Location: 215 S Brady St, Claremore, Oklahoma, 74017 Phone: (918) 342-2174 |